New York, NY, United States of America

Mats A Svensson

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 13.1

ph-index = 4

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Innovations and Contributions of Mats A. Svensson

Introduction

Mats A. Svensson is a prominent inventor based in New York, NY, known for his significant contributions to the field of integrin inhibitors. With a total of 11 patents to his name, he has made remarkable strides in developing therapeutic solutions for various diseases and conditions.

Latest Patents

Among his latest patents are the "Inhibitors of (αv)(β6) integrin," which disclose small molecule inhibitors aimed at treating a range of diseases. Another notable patent is for "Antagonists of human integrin α4β7," which details small molecule antagonists designed to address specific diseases or conditions.

Career Highlights

Mats A. Svensson is currently associated with Morphic Therapeutics, Inc., where he continues to innovate and contribute to the advancement of medical therapies. His work focuses on the development of integrin-targeted treatments that have the potential to improve patient outcomes.

Collaborations

Mats collaborates with talented individuals such as Bryce Alden Harrison and Matthew Gregory Bursavich, enhancing the innovative capabilities of his team.

Conclusion

Mats A. Svensson's work in the field of integrin inhibitors showcases his dedication to advancing medical science through innovation. His contributions are paving the way for new therapeutic options that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…